SPORETIK is indicated in the treatment of the following infections when caused by susceptible strains of the designated microorganisms: Uncomplicated urinary-tract infections caused by Escherichia coli and Proteus mirabilis, e.g. cystitis, cystourethritis, uncomplicated pyelonephritis.
Upper respiratory-tract infections: Otitis media caused by Haemophilus influenzae (beta-lactamase positive and negative strains), Moraxella (Branhamella) catarrhalis (most of which are beta-lactamase positive) and Streptococcus pyogenes; Pharyngitis and tonsillitis caused by Streptococcus pyogenes.
Lower respiratory-tract infections, e.g. acute bronchitis and acute exacerbations of chronic bronchitis, caused by Streptococcus pneumoniae and Haemophilus influenzae (beta-lactamase positive and negative strains).